Cancer

Items 1401-1410 of 2189

per page
Set Descending Direction
  1. GITRL, Soluble (human) (rec.)
    CHI-AG-40A-0019
    CHI-AG-40A-0019-C05050 µg
    CHF 470.00
  2. GITRL, Soluble (human) (rec.) (His)
    AG-40A-0024T
    AG-40A-0024T-C01010 µg
    CHF 145.00
    AG-40A-0024T-C05050 µg
    CHF 420.00
  3. GITRL, Soluble (mouse) (rec.)
    AG-40A-0008
    AG-40A-0008-C05050 µg
    CHF 350.00
    GITRL, Soluble (mouse) (rec.) (Prod. No. AG-40A-0008) induced GITR-mediated NF-κB activation.  HEK293 cells were transiently transfected with 20ng of a (NF-κB)-Luc reporter, 2ng of a Renilla luciferase, and with 20ng of a GITR full lengt
  4. Glabridin
    CAS  59870-68-7
    CDX-G0194
    CDX-G0194-M0055 mg
    CHF 61.00
    CDX-G0194-M02525 mg
    CHF 115.00
    Glabridin
  5. Globosuxanthone A
    CAS  917091-74-8
    AG-CN2-0174
    AG-CN2-0174-C250250 µg
    CHF 90.00
    AG-CN2-0174-M0011 mg
    CHF 270.00
    Globosuxanthone A
  6. GLPG0634
    CAS  1206161-97-8
    SYN-1158
    SYN-1158-M0011 mg
    CHF 270.00
    SYN-1158-M0055 mg
    CHF 454.00
    SYN-1158-M01010 mg
    CHF 653.00
    SYN-1158-M05050 mgINQ
    SYN-1158-M100100 mgINQ
    GLPG0634
  7. Glycitein
    CAS  40957-83-3
    CDX-G0213
    CDX-G0213-M01010 mg
    CHF 88.00
    CDX-G0213-M02525 mg
    CHF 162.00
    Glycitein
  8. Glycochenodeoxycholic acid . sodium salt
    CAS  16564-43-5
    CDX-G0033
    CDX-G0033-M500500 mg
    CHF 150.00
    CDX-G0033-G0011 g
    CHF 264.00
    Glycochenodeoxycholic acid . sodium salt
  9. Glycyrrhizic acid ammonium salt
    CAS  53956-04-0
    CDX-G0215
    CDX-G0215-G02525 g
    CHF 75.00
    CDX-G0215-G100100 g
    CHF 272.00
    Glycyrrhizic acid ammonium salt
  10. GNE-493
    CAS  1033735-94-2
    SYN-1115
    SYN-1115-M0011 mg
    CHF 270.00
    SYN-1115-M0055 mg
    CHF 546.00
    SYN-1115-M01010 mg
    CHF 766.00
    SYN-1115-M05050 mgINQ
    SYN-1115-M100100 mgINQ
    GNE-493

Items 1401-1410 of 2189

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.